| COMPANY | Plum, Bengaluru: employee health benefits and group health insurance platform, founded 2019 by Abhishek Poddar (co-founder and CEO) and Saurabh Arora |
|---|
| ROUND | Series B of ₹193 Cr, about US$20.5m (Entrepreneur India) or US$20.6m (Inc42, fintech.global) · announced 26 March 2026 · the brief said 2025; the sources say 2026 |
| INVESTORS | Peak XV Partners (lead, existing) · Tanglin Venture Partners (existing, higher stake) · GMO VenturePartners, Japan (new) |
| VALUATION AND STAKES | Not published |
| USE OF FUNDS | Talent, technology and enterprise-grade security, AI-driven claims operations, HR and payroll integrations, preventive, primary, mental wellness and telehealth care |
| SCALE (COMPANY) | 6,000+ organisations · 600,000+ employees covered · 500,000+ claims processed · NPS 79 (fintech.global) |
| PROFITABILITY | Company claims its first full year of EBITDA and cash-flow profitability; no year or figures published |
| PRIOR ROUND | Series A of about US$15.6m led by Tiger Global, announced around 31 May 2021 (a fintech.global link is dated January 2021) |
| THE ACCESS POINT
Plum is privately held and no listing is reported in the sources read. Employees reach its cover through an employer's group policy, and its consumer pages list Max Bupa and Star Health for personal plans. |
|---|
Executive decision summary
| THE BOTTOM LINE | Plum is a Bengaluru platform that sells and manages group health insurance for employers, and on 26 March 2026 it announced a ₹193 crore Series B led by Peak XV Partners. The round is dated 2026, not 2025 as the research brief stated. Tanglin Venture Partners increased its stake and GMO VenturePartners of Japan joined as a new investor. Valuation, stakes and structure are not published. Plum says it reached its first full year of EBITDA and cash-flow profitability, but gives no year or figure. The only financial figures found, on Inc42's data page for FY25, conflict: one section shows revenue of ₹69.9 crore and the other ₹13.9 crore. The insurers behind Plum's group policies are not named in any page read, and no source links Universal Sompo, Edelweiss or Tokio to Plum. |
|---|
| WHICH INVESTOR | Plum fits a private-markets watch-list IF you want a venture-backed insurtech with a recognised lead investor and a large employer client base.
Wait IF you need a published valuation, audited revenue and profit, or the names of the insurers that carry the risk: none was found. |
| COMFORT FIT | Group health insurance = one policy that covers many employees under their employer.
Series B = the second major venture round after the first, usually used to scale a proven product.
EBITDA = operating profit before interest, tax, depreciation and amortisation.
TPA = a third-party administrator that handles insurance claims on behalf of insurers. |
| THE RUPEIA NUMBER | ₹193 Cr. The size of Plum's Series B, announced on 26 March 2026 and led by Peak XV Partners, about US$20.5 to 20.6 million. |
1 CLAIM REGISTER: EVIDENCE GRADING
| Claim | Source | Grade | Rupeia assessment |
|---|
| Series B of ₹193 Cr led by Peak XV, 26 March 2026 | Inc42; StartupTalky; Entrepreneur India; fintech.global | B | Established; the brief's 2025 date was wrong |
| US$20.5m or US$20.6m equivalent | Entrepreneur India; Inc42 and fintech.global | B | Both shown; the difference is rounding or rate |
| Tanglin (existing, higher stake) and GMO VenturePartners (new) | Inc42; StartupTalky | B | Established |
| Valuation, stakes and structure | All pages read | D | Not published |
| First full year of EBITDA and cash-flow profitability | Company claim via 2026 coverage | D | No year or figures published |
| FY25 revenue ₹69.9 Cr and ₹13.9 Cr | Inc42 financials page | D | Two figures on one page conflict |
| 6,000+ organisations, 600,000+ employees, 500,000+ claims | StartupTalky; Entrepreneur India; Inc42 | C | Company figures, no methodology |
| Series A of about US$15.6m led by Tiger Global, 2021 | Entrepreneur India (2021); fintech.global headline | B | Established; announcement date differs by source |
| Universal Sompo, Edelweiss or Tokio as Plum insurers | None found | D | No source; insurers not published |
2 THE SERIES B ROUND
| Item | Detail |
|---|
| Amount | ₹193 Cr; US$20.5m per Entrepreneur India, US$20.6m per Inc42 and fintech.global |
| Date | 26 March 2026 (Inc42, Entrepreneur India, fintech.global) |
| Lead | Peak XV Partners, an existing investor per Inc42; GV Ravishankar, Managing Director, is quoted in the announcement (StartupTalky) |
| Other investors | Tanglin Venture Partners (existing, increased stake); GMO VenturePartners, Japan (new) |
| Stakes, valuation, structure | Not published (Entrepreneur India notes stakes were not disclosed) |
| Use of funds | Talent; technology and enterprise-grade security; AI-driven claims operations; HR and payroll integrations; preventive, primary, mental wellness and telehealth care (Inc42). fintech.global adds reaching 10 million people |
| Calculation (Rupeia) | Result |
|---|
| Exchange rate implied by Entrepreneur India | ₹1,930 million ÷ US$20.5 million = ₹94.1 per US$ |
| Exchange rate implied by Inc42 and fintech.global | ₹1,930 million ÷ US$20.6 million = ₹93.7 per US$ |
| Round at ₹96.5 per US$ | ₹1,930 million ÷ ₹96.5 = US$20.0 million |
| Round against the FY25 revenue of ₹69.9 Cr | ₹193 Cr ÷ ₹69.9 Cr = 2.76x |
| Round against the FY25 revenue of ₹13.9 Cr | ₹193 Cr ÷ ₹13.9 Cr = 13.9x |
| RUPEIA READ
The round is confirmed by four sources, and the two dollar figures reflect the exchange rate used when the news was written. At today's ₹96.5 the round is about US$20.0 million. The most important missing piece is the price: without a valuation the size of the stake that new investors bought cannot be known. |
|---|
3 PRIOR FUNDING AND THE VALUATION GAP
| Item | Detail | Source |
|---|
| Series A size | About US$15.6m (Entrepreneur India, fintech.global); about US$15.7m (Entrackr, search snippet) | Entrepreneur India 2021; snippets |
| Series A lead | Tiger Global; Entrackr puts Tiger at about US$10m | Entrackr, snippet |
| Other Series A participants | Surge, Tanglin, Incubate Fund, Gemba | Search snippets |
| Series A date | Around 31 May 2021; the fintech.global link carries 6 January 2021 | Conflict between sources |
| Series A post-money | About US$87m, Entrackr's own estimate; not company-published | Entrackr, snippet |
| Series B valuation | Not published | All pages read |
| Calculation (Rupeia) | Result |
|---|
| Series A plus Series B (Entrepreneur India figures) | US$15.6m + US$20.5m = US$36.1m; earlier funding is not in the sources read |
| Series B against Series A | 20.5 ÷ 15.6 = 1.31x |
| Tiger Global share of the Series A | 10 ÷ 15.7 = 63.7% |
| Series A stake at the estimated post-money | 15.7 ÷ 87 = 18.0% |
| Gap between the rounds | 5 × 12 = 60 months of whole years; 58 months from May 2021 (two months short), 62 months from January 2021 (two months over) |
| Illustration only: post-money if US$20.5m bought 10%, 15% or 20% | 20.5 ÷ 0.10 = US$205m; 20.5 ÷ 0.15 = US$136.7m; 20.5 ÷ 0.20 = US$102.5m |
| RUPEIA READ
The Series B is 1.31 times the Series A in dollars, which is steady growth in round size over about five years. The illustration spans about US$103 million to US$205 million depending on a stake that is not published; these are arithmetic examples, not reported figures. |
|---|
4 SCALE AND CUSTOMERS
| Measure | Figure | Source |
|---|
| Organisations served | 6,000+ | StartupTalky; Entrepreneur India |
| Employees covered | 600,000+ | StartupTalky; Entrepreneur India |
| Claims processed | 500,000+ | Inc42; StartupTalky |
| Net Promoter Score | 79 | fintech.global |
| Reach target | 10 million people | fintech.global |
| Named clients | CRED, Meesho, PhonePe, Swiggy, Tata CLiQ, Urban Company, WeWork, Zomato; Atlassian (Inc42 only) | Inc42; StartupTalky |
| Calculation (Rupeia) | Result |
|---|
| Employees per organisation | 600,000 ÷ 6,000 = 100 |
| Claims per covered employee | 500,000 ÷ 600,000 = 0.83 |
| Reach target against current cover | 10,000,000 ÷ 600,000 = 16.7x |
| Round per covered employee | ₹1,930 million ÷ 0.6 million = ₹3,217 |
| Named clients | 8 + 1 = 9 (Atlassian is listed by Inc42 only) |
| RUPEIA READ
An average of 100 covered employees per organisation points to many mid-sized employers, though the named clients are well-known technology and consumer companies. The 10 million figure is a target with no stated timeline or method, not current coverage. All scale figures are company claims. |
|---|
5 FINANCIALS: TWO SETS OF FY25 FIGURES
| Inc42 FY25 (year to March 2025) | FAQ section | Summary box |
|---|
| Revenue | ₹69.9 Cr (₹45.3 Cr in FY24) | ₹13.9 Cr (up 14%) |
| Loss | Net loss ₹14.0 Cr | PAT −₹12.2 Cr |
| EBITDA | Estimated −₹12.6 Cr | Not given |
| Expenses and assets | Not given | Expenses ₹26.1 Cr; total assets ₹76.3 Cr |
| Calculation (Rupeia) | Result |
|---|
| FAQ revenue growth | ₹69.9 Cr ÷ ₹45.3 Cr = 1.543x, so growth of 54.3% |
| FAQ net loss margin | ₹14.0 Cr ÷ ₹69.9 Cr = 20.0% |
| FAQ EBITDA margin | ₹12.6 Cr ÷ ₹69.9 Cr = 18.0% |
| Summary box: revenue less expenses | ₹13.9 Cr − ₹26.1 Cr = −₹12.2 Cr, matching its PAT |
| Summary box loss margin | ₹12.2 Cr ÷ ₹13.9 Cr = 87.8% |
| Gap between the two revenue figures | ₹69.9 Cr − ₹13.9 Cr = ₹56.0 Cr; ₹69.9 Cr ÷ ₹13.9 Cr = 5.0x |
| Round against the summary-box loss | ₹193 Cr ÷ ₹12.2 Cr = 15.8 years at that loss |
| RUPEIA READ
The summary-box figures are consistent with each other, and so are the FAQ figures, but the two sets cannot both be right: revenue differs five-fold. Inc42 says its data comes from public filings; the figures were not checked against registrar filings. Both sets show a loss in FY25, so the 2026 profitability claim refers to a later, unquantified period. |
|---|
6 PEOPLE AND ORIGINS
| Person or item | Detail | Source |
|---|
| Abhishek Poddar | Co-founder and CEO of Plum; a 2021 snippet describes a Stanford alumnus who worked at Google and McKinsey | Inc42; StartupTalky; Entrackr snippet |
| Saurabh Arora | Co-founder; title not stated in 2026 coverage; a 2021 snippet says they led product and engineering at Freshworks and built Airwoot | Snippet |
| GV Ravishankar | Managing Director, Peak XV Partners, quoted in the 2026 announcement | StartupTalky |
| Founding date | 2019 (Inc42, Entrepreneur India); early 2020 (Entrackr) | Conflict |
| Calculation (Rupeia) | Result |
|---|
| Company age at the Series B, 2019 start | 2026 − 2019 = 7 years |
| Company age at the Series B, 2020 start | 2026 − 2020 = 6 years |
| Days from announcement to this note | 228 days, from 26 March to 9 November 2026 |
| RUPEIA READ
The same two founders are named from the Series A to the Series B. The founding year is a minor conflict between sources, and the 2021 biographies come from search snippets, not full pages. |
|---|
7 INSURERS, COMPETITORS AND IRDAI CONTEXT
| Item | Detail | Source quality |
|---|
| Insurer partners | Not named in the 2026 coverage; consumer pages list Max Bupa and Star Health for personal plans; no source links Universal Sompo, Edelweiss or Tokio to Plum | Plum pages; searches |
| Onsurity | Subscription model for SMEs and startups; a snippet claims about US$66m raised, an older report gives a US$16m Series A led by Quona | Conflict |
| Loop Health | Pune; corporate groups of 100+ employees; CB Insights shows a US$25m round in April 2022 | Search result |
| Acko | No information found in the searches | Not published |
| IRDAI, Dec 2025 | Group health and group PA broker commissions moved to a principle-based framework set by insurers' board-approved policies | Snippet only |
| IRDAI, 2026 | Corporate-agent revision: brokers that do not apply by 31 March 2027 cease to act as brokers; TPA amendment around 30 July 2026 after a 19 June draft; October 2026 distribution reforms are proposals | Snippets only |
| Calculation (Rupeia) | Result |
|---|
| Loop Health round against Plum's Series B | 25 ÷ 20.5 = 1.22x |
| Onsurity Series A against Plum's Series A | 16 ÷ 15.6 = 1.03x |
| Spread in Onsurity funding figures | US$66m − US$16m = US$50m; the figures are not the same round |
| IRDAI TPA draft to amendment | 11 + 30 = 41 days (19 June to 30 July 2026) |
| Days to the broker deadline from this note | 142 days from 9 November 2026 to 31 March 2027 (21 in November, 31 in December, 31 in January, 28 in February, 31 in March) |
| RUPEIA READ
Plum's model depends on insurers it has not named in the sources read, so who carries the claims risk on a given policy sits in the policy document. The IRDAI items come from search snippets, not full texts, and the October 2026 reforms are proposals. They matter because they affect broker economics and TPA rules, but how they apply to Plum is not published. |
|---|
8 RISKS, SCENARIOS AND CHECKLIST
| Risk | Evidence | Severity | Kill condition |
|---|
| Profit claim | Unquantified; FY25 data shows a loss | HIGH | Filings show continuing losses |
| Disclosure | No valuation, stakes or structure published | MEDIUM | Terms prove unfavourable to common holders |
| Data conflict | FY25 revenue ₹69.9 Cr against ₹13.9 Cr | MEDIUM | Lower figure is the filed one |
| Insurer dependence | Underwriters not named | MEDIUM | An insurer limits group capacity |
| Regulation | IRDAI broker and TPA changes in 2025 to 2026 | MEDIUM | Registration or commission rules tighten |
| Competition | Onsurity and Loop Health in the same segment | MEDIUM | Price competition for employers |
| Scenario | What happens | Outcome |
|---|
| Bull | Filings confirm the profit claim and the 10 million reach target is met | Funding case strengthens |
| Base | Round funds product and claims automation; profit stays unquantified | Slow disclosure |
| Bear | Higher FY25 revenue proves wrong and losses continue | Further funding needed |
| Investor class | Fit | Why |
|---|
| Private-markets investor | PARTIAL | Recognised lead investor, but no valuation or audited profit published |
| Employer HR buyer | WATCH | Insurer partners and claims terms are not named |
| Insurtech researcher | FIT | Clear case study of a post-2021 group health platform |
Rupeia does not recommend buying or selling any security and is not a SEBI-registered investment adviser or research analyst. Open items are the valuation, the stakes, the insurer partners, the profitability year and the filed FY25 figures, none of which is published in the sources read.
9 KEY TERMS USED IN THIS REPORT
The terms below are used in this report. Each is explained in plain words.
| Term | Meaning |
|---|
| Series B | The second major venture funding round, used to scale a proven product. |
| Group health insurance | One policy covering many employees under their employer. |
| TPA | Third-party administrator that handles claims for insurers. |
| IRDAI | Insurance Regulatory and Development Authority of India, the insurance regulator. |
| EBITDA | Operating profit before interest, tax, depreciation and amortisation. |
| Post-money valuation | A company's value immediately after a funding round. |
Frequently asked questions
How much did Plum raise in 2026?
Plum announced a Series B of ₹193 crore, about US$20.5 to 20.6 million, on 26 March 2026, led by Peak XV Partners.
Who invested in the Series B?
Peak XV Partners led. Tanglin Venture Partners, an existing investor, increased its stake, and GMO VenturePartners of Japan joined as a new investor.
What is Plum's valuation?
It is not published. Entrackr estimated a post-money of about US$87 million for the 2021 Series A; no figure is published for 2026.
Is Plum profitable?
The company says it had its first full year of EBITDA and cash-flow profitability, with no year or figures. Inc42's FY25 data shows a loss.
Who founded Plum?
Abhishek Poddar (co-founder and CEO) and Saurabh Arora, in 2019 per Inc42 and Entrepreneur India, or early 2020 per Entrackr.
Which insurers work with Plum?
Not named in the 2026 coverage. Plum's consumer pages list Max Bupa and Star Health for personal plans.
Source log
Inc42: Insurtech Startup Plum Nets ₹193 Cr To Expand Employee Health Benefits Platform
StartupTalky: Plum Raises ₹193 Crore Led by Peak XV Partners
Entrepreneur India: Plum Insurance Raises INR 193 Cr in Series B Led by Peak XV
Inc42: Plum financials page
fintech.global: Plum raises Series B to scale claims experience in India
fintech.global: Plum bags $15.6m from Tiger Global
| DISCLAIMER
This document is published strictly for informational, educational and academic record-keeping purposes. The publisher is not a SEBI Registered Investment Adviser (RIA) or Research Analyst (RA). It does not constitute personal investment advice, a financial recommendation, or an offer or solicitation to buy, sell or subscribe to any securities. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. |
|---|